The Portnoy Law Firm said it has opened an investigation into possible securities fraud at Fulgent and may file a securities class action on behalf of investors. Fulgent shares fell USD 9.43, or 38%, to USD 15.33 on February 27, 2026 after the company reported fourth-quarter and full-year 2025 results. The firm said the decline followed Fulgent’s lower-than-expected 2026 guidance, which management attributed to its largest customer moving a significant volume of work in-house. More information is available at https://portnoylaw.com/fulgent-genetics-inc.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fulgent Genetics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603130900PRIMZONEFULLFEED9670689) on March 13, 2026, and is solely responsible for the information contained therein.
Comments